First Light Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

First Light Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-140,801	Closed	-$10.6M	–	77
2022 Q2	$10.6M	Sell	140,801 -67,829	-33%	-$3.01M	1.23%	29
2022 Q1	$5.6M	Sell	208,630 -340,996	-62%	-$11.5M	0.49%	38
2021 Q4	$26.2M	Buy	549,626 +96,748	+21%	+$4.33M	1.88%	22
2021 Q3	$30.1M	Buy	452,878 +57,053	+14%	+$4.06M	1.98%	22
2021 Q2	$30.9M	Buy	395,825 +336,946	+572%	+$24.9M	1.85%	24
2021 Q1	$5.57M	Buy	58,879 +3,198	+6%	+$380K	0.37%	45
2020 Q4	$6.79M	Buy	55,681 +848	+2%	+$92.9K	0.5%	37
2020 Q3	$4.79M	Sell	54,833 -137,996	-72%	-$9.61M	0.49%	37
2020 Q2	$12.5M	Buy	+192,829	New	+$11.1M	1.45%	27

First Light Asset Management's TPTX Position: Q3 2022 in Review

First Light Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 140,801 shares — an estimated $10.6M sold.

First Light Asset Management first reported a position in TPTX in Q2 2020 and held it in 9 quarters. The position peaked at $30.9M in Q2 2021. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

First Light Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
First Light Asset Management sold 140,801 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $10.6M.
First Light Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2020 and held it in 9 quarters.
First Light Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $30.9M in Q2 2021.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on First Light Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.